(3-Methoxy-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

tert-Butyl 4-oxoazepane-1-carboxylate, 98.0%, 1g

Decamethonium Iodide5g

2-(3-METHOXYBENZYL)SUCCINIC ACID, 95.0%, 100mg

anti-Keratin K19 mouse monoclonal, Ks19.2 (Z105.6), 1 ml

1-(4-Chlorophenyl)-2-methoxyethan-1-one, 95+%, 2.5g

ethyl 3-aminohexanoate hydrochloride, 95.0%, 1g

5-Nitro-7-azaindole, 95.0%, 25g

Bis(2,6-dimethylphenyl)amine, 95.0%, 5g

(2S)-2-AMINO-5-[[(1R)-2-(CARBOXYMETHYLAMINO)-1-(NITROSOSULFANYLMETHYL)-2-OXO-ETHYL]AMINO]-5-OXO-PENTANOIC ACID, 95%, 10g

2-Fluoro-N-(piperidine-4-yl)benzamido hydrochloride, 95.0%, 1g

(S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid hydrochloride, 98%, 100mg

2-Chloro-6-methylpyridin-3-ol, 95.0%, 10g